I am a radiation oncologist and scientist committed to improving the lives of people with cancer. Clinically, I treat patients with cancers amenable to radiotherapy, with particular interest in cancers of the gut, including liver and pancreas cancers. For my research, I leverage my expertise in bioengineering, chemistry, pharmacology, and oncology to design, engineer, and test of novel tumor-selective imaging and therapeutic agents for human cancers in general, and liver cancers in particular, with translational intent. I have brought together motivated trainees, and scientists to form the Laboratory of Molecular Radiotherapy within the Molecular Imaging Branch at the National Cancer Institute, with goals to 1) identify tumor selective targets, 2) discover novel biomolecules specific to targets of interest, 3) design, engineer, and test novel radioconjugates from these biomolecules using in vitro assays and in vivo imaging and therapy studies, and 4) conduct clinical studies using next generation radiopharmaceutical imaging and therapeutic agents.